{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:56:01Z","timestamp":1794081361645,"version":"4.8.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2020.00293","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:40:40Z","timestamp":1594964440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID)"],"prefix":"10.3389","volume":"8","author":[{"given":"Kerrie","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Prantner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kurcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Macovei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Pituch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nov\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otakar","family":"Ny\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian K.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Oleastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pedneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United Sates","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/cid\/cis335","article-title":"Burden of Clostridium difficile on the healthcare system","volume":"55","author":"Dubberke","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin Microbiol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOG.0000000000000332","article-title":"Novel antibiotics in development to treat Clostridium difficile infection","volume":"33","author":"Bass\u00e8res","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/QCO.0000000000000320","article-title":"New and emerging therapies for Clostridium difficile infection","volume":"29","author":"Martin","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study. Modernising medical microbiology informatics group","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"5","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1128\/AAC.49.8.3529-3532.2005","article-title":"Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice","volume":"49","author":"Pultz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhoea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmi.2019.02.002","article-title":"Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease","volume":"25","author":"Meltzer","year":"2019","journal-title":"Clin Microb Infect"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J Hosp Infect"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1128\/JCM.03352-12","article-title":"Barcelona Clostridium difficile study group. Epidemiology of Clostridium difficile infection and risk factors for unfavourable clinical outcomes: results of a hospital-based study in Barcelona, Spain","volume":"51","author":"Rodr\u00edguez-Pardo","year":"2013","journal-title":"J Clin Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s10096-012-1603-0","article-title":"Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study","volume":"31","author":"Vesteinsdottir","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/2319-4170.128002","article-title":"Proton pump inhibitors and risk for Clostridium difficile associated diarrhoea","volume":"37","author":"Biswal","year":"2014","journal-title":"Biomed J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/ajg.2016.343","article-title":"Proton pump inhibitors do not increase risk for clostridium difficile infection in the intensive care unit","volume":"111","author":"Faleck","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e110790","DOI":"10.1371\/journal.pone.0110790","article-title":"Acid suppression therapy does not predispose to clostridium difficile infection: the case of the potential bias","volume":"9","author":"Novack","year":"","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/phar.2088","article-title":"derivation and validation of a Clostridium difficile infection recurrence prediction rule in a national cohort of veterans","volume":"38","author":"Reveles","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1017\/ice.2017.176","article-title":"Prediction of recurrent Clostridium difficile infection using comprehensive electronic medical records in an integrated healthcare delivery system","volume":"38","author":"Escobar","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1473-3099(14)70991-0","article-title":"Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)","volume":"14","author":"Davies","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1473-3099(13)70200-7","article-title":"Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection","volume":"13","author":"Planche","year":"2013","journal-title":"Lancet Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection","volume":"22","author":"Crobach","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e98400","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhoea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2049-2618-1-18","article-title":"Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection","volume":"1","author":"Vincent","year":"2013","journal-title":"Microbiome."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","article-title":"Overdiagnosis of Clostridium difficile infection in the molecular test era","volume":"175","author":"Polage","year":"2015","journal-title":"JAMA Intern Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:40:43Z","timestamp":1594964443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2020.00293"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2020.00293","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"article-number":"293"}}